• Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection 

      Shein, Aye Mya Sithu; Wannigama, Dhammika Leshan; Hurst, Cameron; Monk, Peter N.; Amarasiri, Mohan; Badavath, Vishnu Nayak; Phattharapornjaroen, Phatthranit; Ditcham, William Graham Fox; Ounjai, Puey; Saethang, Thammakorn; Chantaravisoot, Naphat; Thuptimdang, Wanwara; Luk-in, Sirirat; Nilgate, Sumanee; Rirerm, Ubolrat; Tanasatitchai, Chanikan; Kueakulpattana, Naris; Laowansiri, Matchima; Liao, Tingting; Kupwiwat, Rosalyn; Rojanathanes, Rojrit; Ngamwongsatit, Natharin; Thammahong, Arsa; Ishikawa, Hitoshi; Pletzer, Daniel; Leelahavanichkul, Asada; Ragupathi, Naveen Kumar Devanga; Wapeesittipan, Pattama; Ali Hosseini Rad, Hosseini; Kanjanabuch, Talerngsak; Storer, Robin James; Miyanaga, Kazuhiko; Cui, Longzhu; Hamamoto, Hiroshi; Higgins, Paul G.; Kicic, Anthony; Chatsuwan, Tanittha; Hongsing, Parichart; Abe, Shuichi (Journal article; Peer reviewed, 2023)
      Given the rise of multidrug-resistant (MDR) Pseudomonas aeruginosa infections, alternative treatments are needed. Anti-pseudomonal phage therapy shows promise, but its clinical application is limited due to the development ...